Epidemiology

  • Most common type of sex cord-stromal malignancy (∼ 90%)
  • Peak age: 50–55 years

Etiology


Pathophysiology


Clinical features

  • Hyperestrogenic manifestations:
    • Juvenile / Prepubertal: Peripheral precocious puberty (isosexual: breast buds, pubic/axillary hair, early vaginal bleeding, accelerated linear growth with premature epiphyseal closure).
    • Reproductive age: Abnormal uterine bleeding (AUB), heavy menstrual bleeding, oligomenorrhea/amenorrhea.
    • Postmenopausal: Postmenopausal bleeding (PMB), breast tenderness, vaginal discharge.
  • Mass effect & local symptoms:
    • Unilateral pelvic pain, fullness, pressure, or palpable adnexal mass on pelvic examination.
    • Acute abdomen secondary to ovarian torsion or tumor rupture with hemoperitoneum.

Diagnostics

  • Initial / Screening Imaging:
    • Transvaginal Ultrasound (TVUS): Large, complex, solid-cystic adnexal mass with a multilocular or “Swiss cheese” appearance; thickened endometrial stripe (> 4 mm in postmenopausal women).
  • Key Labs / Tumor Markers:
    • ↑ Inhibin (Inhibin A and B): Sensitive and specific tumor marker; gold standard for monitoring treatment response and detecting recurrence.
    • ↑ Serum Estradiol (E2).
    • Serum CA-125: Non-specific, may be mildly elevated.
  • Essential Adjunctive Procedure:
    • Endometrial Biopsy (EMB): Mandatory in patients with AUB/PMB or thickened endometrium to rule out concurrent endometrial hyperplasia or cancer. c
  • Confirmatory / Gold Standard:
    • Surgical Staging & Histopathology:
      • Call-Exner bodies: Rosette-like arrangement of granulosa cells around central eosinophilic, fluid-filled spaces.
      • “Coffee-bean” nuclei: Pale, round-to-oval nuclei with longitudinal grooving.
      • Immunohistochemistry (IHC): (+) Calretinin, (+) Inhibin, (+) WT-1, (+) FOXL2.

Mnemonic

Give Granny a Call


Treatment